From: Hypermethylated APC in serous carcinoma based on a meta-analysis of ovarian cancer
First author | Country | Ethnicity | Method | Sample | Cancer | LMP | Benign | Normal | Low-grade | High-grade | StageI-II | Stage III-IV | Serous carcinoma | Non-serous carcinoma |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N (M %) | N (M %) | N (M %) | N (M %) | M/N | M/N | M/N | M/N | M/N | M/N | |||||
Rathi 2002 [30] | USA | Caucasians | MSP | Tissue | 49 (18.4) | - | 16 (0) | - | - | - | - | - | - | - |
Caceres 2004 [29] | USA | Caucasians | MSP | Tissue | 35 (11.4) | 10 (10) | 10 (0) | 10 (0) | 0/12 | 4/23 | 1/8 | 3/27 | 2/21 | 2/14 |
Caceres 2004 [29] | USA | Caucasians | MSP | Blood | 35 (8.6) | 10 (10) | 10 (0) | 20 (0) | 0/12 | 3/23 | 1/8 | 2/27 | 1/21 | 2/14 |
Makarla 2005 [28] | USA | Caucasians | MSP | Tissue | 23 (21.7) | 23 (0) | 23 (0) | 16 (0) | - | - | - | - | 1/9 | 4/14 |
Tam 2007 [27] | China | Asians | MSP | Tissue | 89 (47.2) | 16 (50) | 19 (26.3) | 16 (25) | - | - | - | - | - | - |
Wu 2007 [26] | Norway | Caucasians | MSP | Tissue | 51 (23.5) | 2 (0) | 2 (0) | - | 7/26 | 5/23 | 9/25 | 3/26 | 3/19 | 9/27 |
Shen 2007 [31] | China | Asians | MSP | Tissue | 63 (22.2) | - | - | 30 (0) | - | - | - | - | 4/34 | 10/29 |
Sun 2008 [32] | China | Asians | MSP | Tissue | 59 (32.2) | - | - | 42 (2.4) | 5/36 | 14/23 | 2/21 | 17/38 | 11/30 | 8/29 |
Ho 2010 [25] | China | Asians | MSP | Tissue | 63 (23.8) | - | 10 (0) | 5 (0) | - | - | - | - | 13/48 | 2/15 |
Bhagat 2012 [24] | India | Caucasians | MSP | Tissue | 86 (29.1) | 14 (28.6) | 19 (15.8) | 15 (0) | 10/30 | 15/56 | 6/23 | 19/63 | 11/44 | 14/42 |
Zhang 2013 [23] | China | Asians | MSP | Blood | 20 (35) | - | - | 62 (0) | - | - | - | - | - | - |
Brait 2013 [22] | USA | Caucasians | QMSP | Tissue | 33 (15.1) | - | - | 13 (0) | - | - | - | - | - | - |
Al-Shabanah 2014 [21] | Saudi Arabia | Caucasians | MSP | Tissue | 200 (36) | - | - | 200 (10) | - | - | 28/103 | 44/97 | - | - |